SANDOSTATIN
Total Payments
$1.1M
Transactions
2,127
Doctors
1,441
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $171,525 | 33 | 7 |
| 2023 | $246,242 | 60 | 7 |
| 2022 | $267,006 | 24 | 2 |
| 2021 | $290,692 | 35 | 25 |
| 2020 | $304.61 | 20 | 17 |
| 2019 | $35,355 | 1,834 | 1,354 |
| 2018 | $22,214 | 63 | 46 |
| 2017 | $22,762 | 58 | 42 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $804,215 | 38 | 76.1% |
| Travel and Lodging | $190,219 | 92 | 18.0% |
| Food and Beverage | $31,754 | 1,962 | 3.0% |
| Unspecified | $17,200 | 23 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,593 | 11 | 0.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,120 | 1 | 0.3% |
Payments by Type
General
$1.0M
2,104 transactions
Research
$17,200
23 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $10,859 | 5 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $6,341 | 1 |
Top Doctors Receiving Payments for SANDOSTATIN — Page 58
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Medical Oncology | Zephyrhills, FL | $6.82 | 1 |
| , MD | Hematology & Oncology | Niles, IL | $6.55 | 1 |
| , MD | Hematology & Oncology | Effingham, IL | $4.98 | 1 |
| , M.D | Specialist | Houston, TX | $4.38 | 1 |
| , MD | Hematology & Oncology | The Woodlands, TX | $4.38 | 1 |
| , NP | Family | Richmond, IN | $4.14 | 1 |
| Amit Bansal | Internal Medicine | Richmond, IN | $4.14 | 1 |
| , MD PHD | Neurology | Albany, NY | $3.84 | 1 |
| , MD | Hematology & Oncology | Wichita, KS | $3.60 | 1 |
| , MD | Hematology & Oncology | Wichita, KS | $3.60 | 1 |
| , M.D | Hematology & Oncology | Wichita, KS | $3.60 | 1 |
| , M.D | Internal Medicine | Wichita, KS | $3.60 | 1 |
| , MD | Hematology & Oncology | Wichita, KS | $3.60 | 1 |
| , MD | Medical Oncology | Manhattan, KS | $3.23 | 1 |
| , MD | Internal Medicine | Manhattan, KS | $3.23 | 1 |
| , M.D | Medical Oncology | Tinley Park, IL | $2.08 | 1 |
Ad
Manufacturing Companies
- Novartis Pharmaceuticals Corporation $662,620
- NOVARTIS PHARMACEUTICALS CORPORATION $384,564
- Novartis Pharma AG $8,917
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 1,441
- Transactions 2,127
About SANDOSTATIN
SANDOSTATIN is a drug associated with $1.1M in payments to 1,441 healthcare providers, recorded across 2,127 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2017 to 2024. In 2024, $171,525 was paid across 33 transactions to 7 doctors.
The most common payment nature for SANDOSTATIN is "Consulting Fee" ($804,215, 76.1% of total).
SANDOSTATIN is associated with 2 research studies, including "RESEARCH RELATED PUBLICATION SUPPORT" ($10,859).